不同 ancestry 儿童急性淋巴细胞白血病中 NUDT15 新变异与硫嘌呤不耐受
该研究在来自新加坡、台湾和圣犹大儿童研究医院的 5 例急性淋巴细胞白血病(ALL)患儿中描述了 3 个新的 NUDT15 编码变异(p.R34T、p.K35E 和 p.G17_V18del)。携带这些变异的患者在接受方案治疗时出现显著毒性和对巯嘌呤(MP)耐受性降低。功能上,3 个变异均导致 NUDT15 核苷二磷酸酶活性部分至完全丧失并负面影响蛋白稳定性。p.G17_V18del 变异蛋白热稳定性极低且完全无催化活性,可能 confer 高硫嘌呤不耐受风险;该框内缺失仅见于非洲和欧洲患者,是首次在非亚洲、非西班牙裔人群中发现的 NUDT15 风险变异。
要点
- 在 5 例 ALL 患儿中鉴定出 3 个新的 NUDT15 编码变异:p.R34T、p.K35E 和 p.G17_V18del。
- 携带这些变异的患者在接受方案治疗时出现显著毒性和对巯嘌呤(MP)耐受性降低。
- p.G17_V18del 变异蛋白热稳定性极低且完全无催化活性,可能 confer 高硫嘌呤不耐受风险。
核心结论
- 发现了 3 个与 MP 毒性相关的 NUDT15 新功能缺失变异,有助于在不同人群中更全面地基于药物遗传学调整硫嘌呤剂量。
研究设计与样本
- 在来自新加坡、台湾和圣犹大儿童研究医院的前线方案入组的 5 例 ALL 患儿中描述 3 个新的 NUDT15 编码变异。
主要发现
- 携带 p.R34T、p.K35E 或 p.G17_V18del 变异的患者在接受方案治疗时出现显著毒性和对 MP 耐受性降低。
- 3 个变异均导致 NUDT15 核苷二磷酸酶活性部分至完全丧失并负面影响蛋白稳定性。
- p.G17_V18del 变异蛋白热稳定性极低且完全无催化活性,可能 confer 高硫嘌呤不耐受风险。
- p.G17_V18del 框内缺失仅见于非洲和欧洲患者,是首次在非亚洲、非西班牙裔人群中发现的 NUDT15 风险变异。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prolonged exposure to thiopurines (eg, mercaptopurine [MP]) is essential for curative therapy in acute lymphoblastic leukemia (ALL), but is also associated with frequent dose-limiting hematopoietic toxicities, which is partly explained by inherited genetic polymorphisms in drug metabolizing enzymes (eg, TPMT). Recently, our group and others identified germ line genetic variants in NUDT15 as another major cause of thiopurine-related myelosuppression, particularly in Asian and Hispanic people. In this article, we describe 3 novel NUDT15 coding variants (p.R34T, p.K35E, and p.G17_V18del) in 5 children with ALL enrolled in frontline protocols in Singapore, Taiwan, and at St. Jude Children's Research Hospital. Patients carrying these variants experienced significant toxicity and reduced tolerance to MP across treatment protocols. Functionally, all 3 variants led to partial to complete loss of NUDT15 nucleotide diphosphatase activity and negatively influenced protein stability. In particular, the p.G17_V18del variant protein showed extremely low thermostability and was completely void of catalytic activity, thus likely to confer a high risk of thiopurine intolerance. This in-frame deletion was only seen in African and European patients, and is the first NUDT15 risk variant identified in non-Asian, non-Hispanic populations. In conclusion, we discovered 3 novel loss-of-function variants in NUDT15 associated with MP toxicity, enabling more comprehensive pharmacogenetics-based thiopurine dose adjustments across diverse populations.
引用
- Moriyama T, Yang YL, Nishii R, et al. Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry. Blood. 2017. PMID: 28659275. doi:10.1182/blood-2017-05-782383
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。